Childhood pemphigus vulgaris successfully treated with rituximab
- PMID: 22960821
- DOI: 10.4103/0378-6323.100587
Childhood pemphigus vulgaris successfully treated with rituximab
Abstract
Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an 11-year-old boy of childhood pemphigus vulgaris who failed to respond to dexamethasone pulse therapy and was subsequently treated with rituximab and achieved complete remission.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
